InsidersTradesSigma
Follow the Genomtec S.A. stock price and the full management transaction log of the company, a listed issuer based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, Genomtec S.A. has published 6 public disclosures. Market capitalisation: €69.8m. The latest transaction was filed on 18 May 2026 (Subscription). All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Genomtec S.A. es una empresa centrada en el desarrollo de soluciones de diagnóstico molecular. Su objetivo es mejorar las pruebas de salud a través de tecnologías innovadoras.